Biotechnology
The Biotechnology industry has a total of 596 stocks, with a combined market cap of $1.27 trillion and total revenue of $123.27 billion.
Market Cap
1.27T
Revenue
123.27B
Profits
-34.09B
PE Ratio
n/a
Profit Margin
-27.65%
Dividend Yield
0.04%
596 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 136.01B | 0.42% | 1,292,404 | 12.95B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 94.88B | -1.28% | 705,145 | 16.90B |
| 3 | MRNA | Moderna, Inc. | 79.63B | -4.84% | 6,986,350 | 2.53B |
| 4 | ARGX | argenx SE | 58.93B | -0.66% | 309,893 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 46.10B | -2.34% | 243,134 | 6.45B |
| 6 | RPRX | Royalty Pharma plc | 39.39B | -0.01% | 3,361,571 | 2.62B |
| 7 | RVMD | Revolution Medicines, Inc. | 34.57B | -1.76% | 2,340,166 | 197.56M |
| 8 | GMAB | Genmab A/S | 32.46B | -1.91% | 2,957,021 | 4.30B |
| 9 | ROIV | Roivant Sciences Ltd. | 28.06B | 0.05% | 3,724,439 | 41.08M |
| 10 | INSM | Insmed Incorporated | 26.28B | -1.69% | 1,944,160 | 1.52B |
| 11 | INCY | Incyte Corporation | 24.01B | -1.08% | 1,211,020 | 6.01B |
| 12 | BNTX | BioNTech SE | 20.64B | -1.89% | 1,242,097 | 2.75B |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.01B | -4.54% | 2,518,054 | 5.01B |
| 14 | ASND | Ascendis Pharma A/S | 17.73B | -0.32% | 568,039 | 1.37B |
| 15 | EXEL | Exelixis, Inc. | 16.66B | -0.31% | 1,818,737 | 2.50B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.90B | 2.93% | 721,425 | 4.72B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 15.20B | 1.58% | 3,652,471 | 945.54M |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 11.90B | 4.99% | 3,067,025 | 3.66B |
| 19 | TECH | Bio-Techne Corporation | 11.43B | 0.17% | 2,628,447 | 1.23B |
| 20 | HALO | Halozyme Therapeutics, Inc. | 10.92B | -0.18% | 1,609,280 | 1.80B |
| 21 | KYMR | Kymera Therapeutics, Inc. | 10.34B | -0.32% | 677,504 | 102.24M |
| 22 | SYRE | Spyre Therapeutics, Inc. | 9.64B | 8.15% | 1,371,887 | - |
| 23 | KRYS | Krystal Biotech, Inc. | 9.34B | 5.62% | 345,855 | 470.03M |
| 24 | PCVX | Vaxcyte, Inc. | 9.26B | -1.48% | 1,128,790 | - |
| 25 | TGTX | TG Therapeutics, Inc. | 9.26B | 5.44% | 1,870,858 | 897.76M |
| 26 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.25B | -5.67% | 634,561 | 1.43B |
| 27 | MTRI | Mentari Therapeutics, Inc. | 9.19B | -12.66% | 215,226 | - |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 8.53B | 0.04% | 425,744 | 7.46M |
| 29 | SMMT | Summit Therapeutics Inc. | 8.40B | -1.59% | 12,095,254 | - |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 8.30B | 2.00% | 432,808 | 551.69M |
| 31 | RYTM | Rhythm Pharmaceuticals, Inc. | 8.25B | 2.08% | 2,126,707 | 280.75M |
| 32 | TWST | Twist Bioscience Corporation | 7.93B | 3.88% | 2,226,182 | 459.43M |
| 33 | CORT | Corcept Therapeutics Incorporated | 7.42B | -3.25% | 744,849 | 963.65M |
| 34 | ABVX | ABIVAX Société Anonyme | 7.33B | 2.11% | 1,194,760 | 5.33M |
| 35 | CYTK | Cytokinetics, Incorporated | 7.15B | -0.64% | 1,594,482 | 113.29M |
| 36 | CGON | CG Oncology, Inc. | 7.15B | 1.34% | 1,796,102 | 6.17M |
| 37 | IBRX | ImmunityBio, Inc. | 7.13B | 7.03% | 15,869,693 | 182.57M |
| 38 | AXSM | Axsome Therapeutics, Inc. | 7.05B | -1.43% | 743,588 | 865.27M |
| 39 | IMVT | Immunovant, Inc. | 6.86B | -0.12% | 907,602 | - |
| 40 | ORKA | Oruka Therapeutics, Inc. | 6.49B | -0.60% | 520,534 | - |
| 41 | KOD | Kodiak Sciences Inc. | 6.38B | 1.04% | 744,722 | - |
| 42 | BLTE | Belite Bio, Inc | 6.29B | -0.94% | 94,254 | - |
| 43 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.09B | 0.28% | 2,421,436 | 450.82M |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 6.04B | 0.59% | 498,219 | 670.78M |
| 45 | LGND | Ligand Pharmaceuticals Incorporated | 5.98B | 1.67% | 381,389 | 253.83M |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.86B | 6.48% | 2,774,430 | 570.00K |
| 47 | CAI | Caris Life Sciences, Inc. | 5.59B | -2.21% | 3,916,387 | 1.05B |
| 48 | MANE | Veradermics, Incorporated | 5.27B | -0.62% | 265,391 | - |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.03B | -0.22% | 642,751 | 1.16B |
| 50 | COGT | Cogent Biosciences, Inc. | 4.84B | -0.14% | 2,705,363 | - |
| 51 | ERAS | Erasca, Inc. | 4.83B | -0.94% | 8,941,554 | - |
| 52 | TVTX | Travere Therapeutics, Inc. | 4.82B | -1.68% | 844,306 | 651.03M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.73B | -3.45% | 861,558 | 2.72M |
| 54 | IONS | Ionis Pharmaceuticals, Inc. | 4.56B | 1.59% | 3,226,884 | 960.09M |
| 55 | EWTX | Edgewise Therapeutics, Inc. | 4.53B | -1.59% | 866,813 | - |
| 56 | DFTX | Definium Therapeutics, Inc. | 3.99B | -0.88% | 1,915,329 | - |
| 57 | CRSP | CRISPR Therapeutics AG | 3.90B | 0.10% | 3,978,927 | 25.17M |
| 58 | TARS | Tarsus Pharmaceuticals, Inc. | 3.74B | -2.88% | 456,221 | 682.20M |
| 59 | XENE | Xenon Pharmaceuticals Inc. | 3.71B | -2.66% | 1,364,350 | 7.50M |
| 60 | TNGX | Tango Therapeutics, Inc. | 3.71B | -1.00% | 2,746,145 | 53.81M |
| 61 | SLS | SELLAS Life Sciences Group, Inc. | 3.66B | -6.27% | 35,754,759 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 3.65B | 0.24% | 2,463,223 | 10.35M |
| 63 | ABCL | AbCellera Biologics Inc. | 3.60B | -0.09% | 2,591,183 | 67.85M |
| 64 | PBLS | Parabilis Medicines, Inc. | 3.57B | 0.78% | 602,343 | 2.26M |
| 65 | IRON | Disc Medicine, Inc. | 3.55B | 1.84% | 949,757 | - |
| 66 | ARQT | Arcutis Biotherapeutics, Inc. | 3.49B | 1.02% | 837,679 | 508.68M |
| 67 | IOVA | Iovance Biotherapeutics, Inc. | 3.46B | -0.66% | 7,008,731 | 378.98M |
| 68 | VRDN | Viridian Therapeutics, Inc. | 3.42B | 0.20% | 1,493,085 | 26.31M |
| 69 | VKTX | Viking Therapeutics, Inc. | 3.34B | -2.64% | 2,888,048 | - |
| 70 | ELVN | Enliven Therapeutics, Inc. | 3.30B | -4.18% | 747,582 | - |
| 71 | LEGN | Legend Biotech Corporation | 3.15B | 0.87% | 2,152,080 | 1.36B |
| 72 | ACAD | Acadia Pharmaceuticals Inc. | 3.08B | -2.67% | 1,895,605 | 1.20B |
| 73 | TLX | Telix Pharmaceuticals Limited | 3.01B | 1.13% | 418,746 | 890.79M |
| 74 | ADMA | ADMA Biologics, Inc. | 3.01B | -0.51% | 3,178,042 | 519.15M |
| 75 | VCEL | Vericel Corporation | 2.99B | 1.33% | 832,419 | 324.17M |
| 76 | DYN | Dyne Therapeutics, Inc. | 2.97B | -0.94% | 2,928,460 | - |
| 77 | DNLI | Denali Therapeutics Inc. | 2.95B | 2.22% | 2,368,841 | 21.38M |
| 78 | CELC | Celcuity Inc. | 2.73B | -4.15% | 1,017,407 | - |
| 79 | MBX | MBX Biosciences, Inc. | 2.65B | 0.60% | 726,473 | - |
| 80 | XNCR | Xencor, Inc. | 2.58B | -0.32% | 867,068 | 200.49M |
| 81 | IDYA | IDEAYA Biosciences, Inc. | 2.56B | -3.32% | 1,452,452 | 36.54M |
| 82 | ZLAB | Zai Lab Limited | 2.49B | -6.03% | 1,042,532 | 441.73M |
| 83 | NAMS | NewAmsterdam Pharma Company N.V. | 2.37B | 1.81% | 1,795,455 | 25.94M |
| 84 | RCUS | Arcus Biosciences, Inc. | 2.27B | -3.84% | 1,973,101 | 100.00M |
| 85 | PHVS | Pharvaris N.V. | 2.23B | -2.26% | 390,157 | - |
| 86 | LKFT | Lakefront Biotherapeutics NV | 2.20B | -0.93% | 148,433 | 1.13B |
| 87 | CLDX | Celldex Therapeutics, Inc. | 2.16B | -1.75% | 679,591 | 158.00K |
| 88 | PVLA | Palvella Therapeutics, Inc. | 2.14B | 1.54% | 118,875 | - |
| 89 | BEAM | Beam Therapeutics Inc. | 2.09B | 1.74% | 4,866,853 | 146.64M |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.03B | -1.75% | 761,774 | 321.74M |
| 91 | IMNM | Immunome, Inc. | 1.98B | -2.33% | 1,412,355 | 4.02M |
| 92 | FTRE | Fortrea Holdings Inc. | 1.98B | 4.65% | 1,592,963 | 2.67B |
| 93 | BHVN | Biohaven Ltd. | 1.95B | -2.57% | 2,323,924 | - |
| 94 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | 0.30% | 565,813 | 989.36M |
| 95 | TRVI | Trevi Therapeutics, Inc. | 1.93B | 0.00% | 2,065,583 | - |
| 96 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.92B | 1.37% | 1,408,355 | 213.00M |
| 97 | REPL | Replimune Group, Inc. | 1.88B | 0.61% | 2,130,075 | - |
| 98 | SEPN | Septerna, Inc. | 1.88B | -1.42% | 298,914 | 96.27M |
| 99 | TRAX | First Tracks Biotherapeutics, Inc. | 1.87B | 2.13% | 751,349 | - |
| 100 | VERA | Vera Therapeutics, Inc. | 1.85B | -2.37% | 949,036 | 10.28M |
| 101 | COAG | Hemab Therapeutics Holdings, Inc. | 1.83B | 0.23% | 301,257 | - |
| 102 | LYCA | Lycia Therapeutics, Inc. | 1.81B | 1.39% | 383,466 | 4.44M |
| 103 | RARE | Ultragenyx Pharmaceutical Inc. | 1.80B | 6.17% | 5,164,233 | 730.00M |
| 104 | ZYME | Zymeworks Inc. | 1.80B | 0.77% | 1,085,747 | 265.97M |
| 105 | ZBIO | Zenas BioPharma, Inc. | 1.79B | -4.79% | 480,035 | 11.00M |
| 106 | AGIO | Agios Pharmaceuticals, Inc. | 1.78B | -0.70% | 600,069 | 140.84M |
| 107 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | 3.86% | 41,205,210 | 68.23M |
| 108 | STOK | Stoke Therapeutics, Inc. | 1.75B | 1.06% | 972,224 | 28.21M |
| 109 | MAZE | Maze Therapeutics, Inc. | 1.71B | -5.08% | 711,473 | 20.00M |
| 110 | VIR | Vir Biotechnology, Inc. | 1.57B | -1.08% | 2,154,877 | 302.80M |
| 111 | SRPT | Sarepta Therapeutics, Inc. | 1.56B | -1.62% | 1,866,560 | 1.96B |
| 112 | NRIX | Nurix Therapeutics, Inc. | 1.54B | -0.98% | 2,790,318 | 701.94M |
| 113 | MESO | Mesoblast Limited | 1.53B | -2.27% | 132,572 | 120.25M |
| 114 | PGEN | Precigen, Inc. | 1.53B | -0.47% | 4,269,983 | 156.94M |
| 115 | KLRA | Kailera Therapeutics, Inc. | 1.53B | -3.36% | 418,798 | - |
| 116 | KRSA | Korsana Biosciences, Inc. | 1.52B | 2.37% | 247,335 | - |
| 117 | BRVE | Braveheart Bio, Inc. | 1.51B | -1.33% | 706,902 | - |
| 118 | URGN | UroGen Pharma Ltd. | 1.46B | -0.27% | 1,144,304 | 250.25M |
| 119 | QURE | uniQure N.V. | 1.42B | -2.31% | 1,283,831 | 20.17M |
| 120 | DMRA | Damora Therapeutics, Inc. | 1.42B | 1.86% | 580,483 | - |
| 121 | IMCR | Immunocore Holdings plc | 1.42B | -1.08% | 296,509 | 429.30M |
| 122 | ABSI | Absci Corporation | 1.41B | 7.92% | 5,667,576 | 1.49M |
| 123 | ANAB | AnaptysBio, Inc. | 1.40B | 3.18% | 566,852 | 60.04M |
| 124 | RAPP | Rapport Therapeutics, Inc. | 1.39B | -1.52% | 731,316 | 20.00M |
| 125 | NTLA | Intellia Therapeutics, Inc. | 1.37B | -0.10% | 7,232,873 | 52.89M |
| 126 | ADRX | ADARx Pharmaceuticals, Inc. | 1.37B | -7.24% | 654,561 | 6.13M |
| 127 | TYRA | Tyra Biosciences, Inc. | 1.35B | 0.20% | 472,164 | - |
| 128 | NBTX | Nanobiotix S.A. | 1.34B | -2.00% | 44,323 | 13.15M |
| 129 | GENB | Generate Biomedicines, Inc. | 1.34B | 5.49% | 1,050,277 | 21.07M |
| 130 | NUVB | Nuvation Bio Inc. | 1.33B | -3.08% | 5,957,129 | 201.73M |
| 131 | WWB | Windward Bio Group AG | 1.31B | -12.11% | 517,961 | - |
| 132 | NVAX | Novavax, Inc. | 1.31B | 0.00% | 4,260,736 | 411.65M |
| 133 | MNKD | MannKind Corporation | 1.31B | 0.00% | 2,293,549 | 413.37M |
| 134 | INVA | Innoviva, Inc. | 1.31B | 0.55% | 1,310,687 | 438.32M |
| 135 | OCUL | Ocular Therapeutix, Inc. | 1.31B | -1.33% | 3,668,107 | 50.38M |
| 136 | TSHA | Taysha Gene Therapies, Inc. | 1.30B | -0.25% | 3,551,736 | 5.49M |
| 137 | LBRX | LB Pharmaceuticals Inc | 1.30B | -0.60% | 356,412 | - |
| 138 | SVRA | Savara Inc. | 1.27B | 5.36% | 5,542,168 | - |
| 139 | GHRS | GH Research PLC | 1.25B | -0.11% | 461,979 | - |
| 140 | GPCR | Structure Therapeutics Inc. | 1.24B | -4.46% | 1,100,378 | - |
| 141 | SLN | Silence Therapeutics plc | 1.23B | 0.10% | 1,471,176 | 456.00K |
| 142 | AVLN | Avalyn Pharma Inc. | 1.23B | -0.82% | 404,759 | - |
| 143 | MLYS | Mineralys Therapeutics, Inc. | 1.22B | -4.83% | 1,392,765 | - |
| 144 | NKTR | Nektar Therapeutics | 1.18B | -4.15% | 811,349 | 52.19M |
| 145 | KARD | Kardigan, Inc. | 1.15B | -6.60% | 546,424 | - |
| 146 | AAPG | Ascentage Pharma Group International | 1.15B | -0.97% | 1,803 | 94.61M |
| 147 | DRTS | Alpha Tau Medical Ltd. | 1.11B | -0.66% | 641,832 | - |
| 148 | VOR | Vor Biopharma Inc. | 1.10B | -1.93% | 794,108 | - |
| 149 | OMER | Omeros Corporation | 1.08B | 4.53% | 2,530,168 | 74.36M |
| 150 | JBIO | Jade Biosciences, Inc. | 1.07B | 0.58% | 792,228 | - |
| 151 | ANRO | Alto Neuroscience, Inc. | 1.04B | 4.01% | 986,175 | - |
| 152 | INBX | Inhibrx Biosciences, Inc. | 1.02B | -6.90% | 288,903 | 2.00M |
| 153 | SGP | SpyGlass Pharma, Inc. | 993.14M | -5.60% | 94,929 | - |
| 154 | SPTX | Seaport Therapeutics, Inc. | 980.14M | 0.77% | 683,621 | - |
| 155 | IMTX | Immatics N.V. | 928.83M | -3.02% | 1,571,188 | 49.33M |
| 156 | MLTX | MoonLake Immunotherapeutics | 918.30M | -4.09% | 1,346,238 | - |
| 157 | ODTX | Odyssey Therapeutics, Inc. | 909.92M | -2.01% | 369,093 | 99.00K |
| 158 | AKTS | Aktis Oncology, Inc. | 898.35M | -1.29% | 435,008 | 12.39M |
| 159 | LTGO | Latigo Biotherapeutics, Inc. | 882.44M | -3.27% | 209,071 | - |
| 160 | PHAR | Pharming Group N.V. | 866.88M | 3.51% | 5,958 | 386.75M |
| 161 | VSTM | Verastem, Inc. | 865.72M | -7.29% | 3,968,907 | 100.30M |
| 162 | CRVS | Corvus Pharmaceuticals, Inc. | 859.56M | 0.20% | 987,678 | - |
| 163 | CTY | City Therapeutics, Inc. | 827.95M | -4.91% | 252,983 | 14.34M |
| 164 | MGTX | MeiraGTx Holdings plc | 813.12M | -1.65% | 584,715 | 401.91M |
| 165 | BBTX | Bambusa Therapeutics, Inc. | 809.98M | -2.75% | 253,223 | - |
| 166 | RIGL | Rigel Pharmaceuticals, Inc. | 800.84M | -0.91% | 304,828 | 288.21M |
| 167 | ORIC | ORIC Pharmaceuticals, Inc. | 795.08M | -4.37% | 1,385,239 | - |
| 168 | ARDX | Ardelyx, Inc. | 784.28M | -1.89% | 4,746,261 | 468.22M |
| 169 | GLUE | Monte Rosa Therapeutics, Inc. | 775.03M | 0.00% | 1,264,758 | 70.33M |
| 170 | SNDX | Syndax Pharmaceuticals, Inc. | 770.64M | -6.96% | 3,465,199 | 289.68M |
| 171 | LXRX | Lexicon Pharmaceuticals, Inc. | 765.80M | -3.37% | 2,018,983 | 38.54M |
| 172 | OBX | Obsidian Therapeutics, Inc. | 754.25M | 1.16% | 686,209 | - |
| 173 | IVA | Inventiva S.A. | 753.92M | 5.28% | 3,537,750 | 2.81M |
| 174 | AURA | Aura Biosciences, Inc. | 743.09M | -0.14% | 687,826 | - |
| 175 | OABI | OmniAb, Inc. | 740.97M | 0.59% | 1,215,050 | 40.21M |
| 176 | APMD | Apnimed, Inc. | 726.46M | -1.97% | 297,565 | 108.80M |
| 177 | SGMT | Sagimet Biosciences Inc. | 721.53M | 2.64% | 932,576 | - |
| 178 | ATTO | Attovia Therapeutics, Inc. | 709.92M | 4.51% | 337,158 | 1.44M |
| 179 | SLDB | Solid Biosciences Inc. | 708.73M | 1.93% | 1,206,408 | - |
| 180 | IAM | Iambic Therapeutics, Inc. | 699.64M | 3.80% | 377,970 | 18.25M |
| 181 | NVCT | Nuvectis Pharma, Inc. | 697.75M | 5.68% | 189,615 | - |
| 182 | PRME | Prime Medicine, Inc. | 681.67M | -0.52% | 4,621,884 | 7.06M |
| 183 | KURA | Kura Oncology, Inc. | 674.39M | -2.00% | 2,466,840 | 79.31M |
| 184 | ANNX | Annexon, Inc. | 671.49M | 1.44% | 2,976,150 | - |
| 185 | QUIT | Achieve Life Sciences, Inc. | 651.40M | -3.27% | 969,433 | - |
| 186 | GERN | Geron Corporation | 638.38M | -0.91% | 34,974,668 | 217.52M |
| 187 | JANX | Janux Therapeutics, Inc. | 630.80M | -3.73% | 980,519 | 23.29M |
| 188 | ABUS | Arbutus Biopharma Corporation | 630.03M | 1.48% | 2,902,404 | 181.49M |
| 189 | BCAX | Bicara Therapeutics Inc. | 622.71M | -2.29% | 1,302,236 | - |
| 190 | OLMA | Olema Oncology, Inc. | 618.50M | -2.22% | 1,177,994 | - |
| 191 | DSGN | Design Therapeutics, Inc. | 606.42M | -3.76% | 319,943 | - |
| 192 | SRZN | Surrozen, Inc. | 605.02M | 5.87% | 312,924 | 10.53M |
| 193 | DBVT | DBV Technologies S.A. | 602.91M | -3.10% | 136,177 | 3.74M |
| 194 | IMMX | Immix Biopharma, Inc. | 595.91M | -1.25% | 876,386 | - |
| 195 | FDMT | 4D Molecular Therapeutics, Inc. | 589.73M | -3.06% | 679,698 | 96.06M |
| 196 | OBIO | Orchestra BioMed Holdings, Inc. | 587.14M | 7.03% | 1,204,385 | 31.21M |
| 197 | CGEM | Cullinan Therapeutics, Inc. | 584.94M | -2.91% | 1,064,067 | - |
| 198 | ALMS | Alumis Inc. | 570.56M | -9.19% | 2,016,377 | 7.24M |
| 199 | ENTX | Entera Bio Ltd. | 567.69M | 8.67% | 493,397 | 42.00K |
| 200 | AVBP | ArriVent BioPharma, Inc. | 563.78M | 1.96% | 2,696,657 | 5.00M |
| 201 | ANL | Adlai Nortye Group Ltd. | 562.84M | -7.81% | 455,143 | 18.06M |
| 202 | ACRS | Aclaris Therapeutics, Inc. | 555.14M | 3.55% | 2,940,514 | 6.40M |
| 203 | SANA | Sana Biotechnology, Inc. | 554.32M | -1.60% | 2,659,563 | - |
| 204 | ZVRA | Zevra Therapeutics, Inc. | 552.20M | -1.28% | 623,082 | 147.76M |
| 205 | DNA | Ginkgo Bioworks Holdings, Inc. | 547.06M | 1.44% | 2,361,299 | 130.75M |
| 206 | WVE | Wave Life Sciences, Inc. | 546.32M | -2.46% | 2,208,031 | 70.92M |
| 207 | CLYM | Climb Bio, Inc. | 546.27M | -4.91% | 865,345 | - |
| 208 | CBIO | Crescent Biopharma, Inc. | 530.73M | -4.91% | 327,365 | 15.00M |
| 209 | ETRA | Electra Therapeutics, Inc. | 529.13M | 0.96% | 323,440 | - |
| 210 | VALN | Valneva SE | 507.35M | -4.13% | 4,817 | 163.30M |
| 211 | INDP | Indaptus Therapeutics, Inc. | 505.28M | -0.90% | 166,763 | - |
| 212 | HELP | Helus Pharma Inc. | 503.38M | -4.31% | 3,245,957 | - |
| 213 | RGNX | REGENXBIO Inc. | 480.05M | 0.28% | 701,889 | 153.91M |
| 214 | MNPR | Monopar Therapeutics Inc. | 479.46M | -0.44% | 102,622 | - |
| 215 | NGNE | Neurogene Inc. | 479.02M | 0.17% | 248,968 | 925.00K |
| 216 | GYRE | Gyre Therapeutics, Inc. | 475.02M | -4.82% | 466,554 | 110.06M |
| 217 | FENC | Fennec Pharmaceuticals Inc. | 470.62M | -1.84% | 591,909 | 66.37M |
| 218 | CAPR | Capricor Therapeutics, Inc. | 466.88M | -4.52% | 8,383,545 | 11.13M |
| 219 | MDXG | MiMedx Group, Inc. | 464.04M | 0.00% | 1,513,268 | 303.73M |
| 220 | BLSM | BlossomHill Therapeutics, Inc. | 463.74M | -3.57% | 280,081 | - |
| 221 | DMAC | DiaMedica Therapeutics Inc. | 463.49M | 2.51% | 131,292 | - |
| 222 | ASMB | Assembly Biosciences, Inc. | 458.49M | -0.49% | 486,994 | 67.01M |
| 223 | OCS | Oculis Holding AG | 456.20M | -1.60% | 311,564 | 1.12M |
| 224 | STTK | Shattuck Labs, Inc. | 455.24M | -2.61% | 2,075,290 | 1.00M |
| 225 | RZLT | Rezolute, Inc. | 445.84M | 5.85% | 2,931,650 | - |
| 226 | ARVN | Arvinas, Inc. | 443.01M | -0.81% | 1,085,278 | 275.30M |
| 227 | IRLA | IRulya Therapeutics Inc. | 440.06M | 5.57% | 119,776 | - |
| 228 | PRTA | Prothena Corporation plc | 428.77M | 1.09% | 764,256 | 52.74M |
| 229 | OVID | Ovid Therapeutics Inc. | 426.53M | 1.80% | 2,153,759 | 1.45M |
| 230 | TVGN | Tevogen Inc. | 421.69M | 7.91% | 4,982 | - |
| 231 | PHAT | Phathom Pharmaceuticals, Inc. | 420.98M | -3.64% | 1,674,821 | 274.88M |
| 232 | CADL | Candel Therapeutics, Inc. | 417.33M | -1.48% | 1,389,687 | - |
| 233 | EPRX | Eupraxia Pharmaceuticals Inc. | 415.85M | -6.19% | 1,212,153 | - |
| 234 | TECX | Tectonic Therapeutic, Inc. | 411.32M | 4.78% | 169,433 | - |
| 235 | CTMX | CytomX Therapeutics, Inc. | 409.85M | -3.09% | 4,386,509 | 14.03M |
| 236 | AVTX | Avalo Therapeutics, Inc. | 387.41M | -6.03% | 1,580,805 | 59.00K |
| 237 | ALEC | Alector, Inc. | 382.61M | 0.39% | 2,133,488 | 173.47M |
| 238 | IRD | Opus Genetics, Inc. | 378.88M | -3.21% | 751,576 | 7.91M |
| 239 | SLBT | SL Science Holding Limited | 376.32M | 3.90% | 20,111 | 3.27M |
| 240 | MPLT | MapLight Therapeutics, Inc. | 373.78M | 1.22% | 416,883 | - |
| 241 | PBYI | Puma Biotechnology, Inc. | 373.26M | 1.12% | 454,054 | 231.83M |
| 242 | SPRY | ARS Pharmaceuticals, Inc. | 370.95M | 1.10% | 1,695,612 | 122.14M |
| 243 | CTNM | Contineum Therapeutics, Inc. | 362.82M | -3.25% | 204,006 | - |
| 244 | CRMD | CorMedix Inc. | 357.92M | -3.64% | 1,601,377 | 412.49M |
| 245 | ASPE | Aspen Neuroscience, Inc. | 349.23M | 0.08% | 289,107 | - |
| 246 | YDES | YD Bio Limited | 343.53M | 2.54% | 21,734 | 1.24M |
| 247 | LYEL | Lyell Immunopharma, Inc. | 341.49M | 1.61% | 116,090 | 15.00K |
| 248 | PRLD | Prelude Therapeutics Incorporated | 340.76M | -0.60% | 230,538 | 21.57M |
| 249 | LRMR | Larimar Therapeutics, Inc. | 339.06M | 7.86% | 1,407,246 | - |
| 250 | CCCC | C4 Therapeutics, Inc. | 325.01M | -2.17% | 2,750,234 | 32.28M |
| 251 | AVIR | Atea Pharmaceuticals, Inc. | 320.41M | 0.76% | 342,224 | - |
| 252 | INO | Inovio Pharmaceuticals, Inc. | 316.55M | 3.68% | 11,644,194 | 298.90K |
| 253 | PROK | ProKidney Corp. | 314.48M | -5.45% | 1,796,932 | 775.00K |
| 254 | NAUT | Nautilus Biotechnology, Inc. | 309.51M | 2.97% | 4,554,194 | 424.00K |
| 255 | RLMD | Relmada Therapeutics, Inc. | 304.61M | -5.15% | 1,860,806 | - |
| 256 | XFOR | X4 Pharmaceuticals, Inc. | 304.30M | -3.56% | 642,189 | 16.96M |
| 257 | GLSI | Greenwich LifeSciences, Inc. | 302.08M | 10.05% | 715,567 | - |
| 258 | GALT | Galectin Therapeutics Inc. | 300.61M | 2.41% | 233,788 | - |
| 259 | BNTC | Benitec Biopharma Inc. | 298.70M | 1.47% | 128,826 | - |
| 260 | AGEN | Agenus Inc. | 289.58M | 3.06% | 880,308 | 133.95M |
| 261 | SABS | SAB Biotherapeutics, Inc. | 288.28M | 8.47% | 886,258 | 114.70K |
| 262 | AGMB | AgomAb Therapeutics NV | 286.62M | -1.69% | 148,665 | - |
| 263 | EVMN | Evommune, Inc. | 284.49M | -1.99% | 600,357 | 10.00M |
| 264 | FULC | Fulcrum Therapeutics, Inc. | 284.14M | -0.80% | 632,159 | 80.00M |
| 265 | KYTX | Kyverna Therapeutics, Inc. | 283.23M | -4.68% | 1,047,764 | - |
| 266 | AUTL | Autolus Therapeutics plc | 282.32M | -2.75% | 2,559,811 | 137.43M |
| 267 | EIKN | Eikon Therapeutics, Inc. | 280.14M | 0.39% | 392,289 | - |
| 268 | VCRE | Vicore Pharma Holding AB (publ) | 278.12M | -2.17% | 3,476 | 383.48K |
| 269 | IKT | Inhibikase Therapeutics, Inc. | 277.16M | 0.00% | 425,303 | 1.00 |
| 270 | EDIT | Editas Medicine, Inc. | 273.18M | -3.01% | 1,991,191 | 49.83M |
| 271 | TTRX | Turn Therapeutics Inc. | 271.79M | 3.98% | 52,415 | - |
| 272 | DTIL | Precision BioSciences, Inc. | 271.01M | 0.71% | 370,343 | 45.04M |
| 273 | ALT | Altimmune, Inc. | 270.48M | -9.15% | 4,723,823 | 26.00K |
| 274 | SCTX | Scribe Therapeutics Inc. | 266.07M | -10.91% | 273,136 | 14.83M |
| 275 | PEPG | PepGen Inc. | 265.27M | -1.29% | 3,396,450 | - |
| 276 | CAMP | Camp4 Therapeutics Corporation | 257.29M | 2.50% | 194,707 | 5.32M |
| 277 | TRXB | TRex Bio, Inc. | 256.44M | -6.10% | 260,998 | - |
| 278 | QTTB | Q32 Bio Inc. | 255.25M | -1.16% | 261,827 | 53.74M |
| 279 | PLX | Protalix BioTherapeutics, Inc. | 254.64M | 4.86% | 962,924 | 84.69M |
| 280 | OCGN | Ocugen, Inc. | 250.82M | -2.31% | 5,862,330 | 4.78M |
| 281 | IPSC | Century Therapeutics, Inc. | 250.60M | 0.73% | 1,142,209 | 109.16M |
| 282 | CUVL | Clinuvel Pharmaceuticals Limited | 246.77M | -0.92% | 789 | 65.05M |
| 283 | LXEO | Lexeo Therapeutics, Inc. | 244.22M | 3.33% | 1,764,538 | - |
| 284 | ALLO | Allogene Therapeutics, Inc. | 241.11M | -6.48% | 10,551,630 | 4.64M |
| 285 | ENTA | Enanta Pharmaceuticals, Inc. | 239.98M | -5.29% | 811,550 | 63.00M |
| 286 | RCKT | Rocket Pharmaceuticals, Inc. | 235.60M | 0.00% | 2,491,773 | - |
| 287 | KROS | Keros Therapeutics, Inc. | 235.49M | 6.10% | 547,249 | 40.76M |
| 288 | ARCT | Arcturus Therapeutics Holdings Inc. | 231.73M | 0.88% | 637,889 | 30.51M |
| 289 | CABA | Cabaletta Bio, Inc. | 227.59M | 3.43% | 4,159,125 | - |
| 290 | VNDA | Vanda Pharmaceuticals Inc. | 226.76M | -1.57% | 949,053 | 229.28M |
| 291 | IMRX | Immuneering Corporation | 226.67M | 1.16% | 730,703 | - |
| 292 | FTH | Faeth Therapeutics, Inc. | 225.36M | -3.54% | 332,261 | - |
| 293 | BCYC | Bicycle Therapeutics plc | 217.99M | -2.81% | 567,646 | 83.53M |
| 294 | LCTX | Lineage Cell Therapeutics, Inc. | 213.95M | 2.78% | 1,220,902 | 10.84M |
| 295 | ACIU | AC Immune SA | 208.80M | -0.47% | 80,189 | 23.75M |
| 296 | NGEN | NervGen Pharma Corp. | 204.29M | -3.06% | 1,131,125 | - |
| 297 | VTVT | vTv Therapeutics Inc. | 201.95M | -6.13% | 21,716 | 36.84M |
| 298 | DRUG | Bright Minds Biosciences Inc. | 199.74M | 1.22% | 135,370 | - |
| 299 | MDWD | MediWound Ltd. | 194.49M | -0.51% | 168,459 | 10.01M |
| 300 | RNAC | Cartesian Therapeutics, Inc. | 192.17M | 2.94% | 170,208 | 1.03M |
| 301 | ANTX | AN2 Therapeutics, Inc. | 187.82M | 17.02% | 968,053 | - |
| 302 | ACOG | Alpha Cognition Inc. | 187.29M | 8.59% | 281,928 | 20.20M |
| 303 | ARTV | Artiva Biotherapeutics, Inc. | 186.36M | -2.33% | 972,603 | 251.00K |
| 304 | CGEN | Compugen Ltd. | 185.66M | -2.97% | 146,093 | 75.93M |
| 305 | WHWK | Whitehawk Therapeutics, Inc. | 184.70M | 1.62% | 284,172 | 7.15M |
| 306 | TRDA | Entrada Therapeutics, Inc. | 183.63M | 1.41% | 815,427 | 3.98M |
| 307 | VOGX | Vogenx, Inc. | 183.31M | -8.46% | 135,713 | - |
| 308 | SLGL | Sol-Gel Technologies Ltd. | 174.83M | 1.00% | 30,687 | 1.44M |
| 309 | ELDN | Eledon Pharmaceuticals, Inc. | 171.62M | 2.53% | 1,136,661 | - |
| 310 | KRRO | Korro Bio, Inc. | 170.75M | 0.97% | 158,098 | 1.29M |
| 311 | ORMP | Oramed Pharmaceuticals Inc. | 169.16M | 0.52% | 164,331 | 2.00M |
| 312 | PALI | Palisade Bio, Inc. | 168.90M | -6.72% | 5,484,108 | 500.00K |
| 313 | PYXS | Pyxis Oncology, Inc. | 168.65M | -2.08% | 765,009 | 11.04M |
| 314 | IFRX | InflaRx N.V. | 163.58M | -3.48% | 3,047,749 | -38.53K |
| 315 | ABEO | Abeona Therapeutics Inc. | 156.01M | 5.00% | 1,705,744 | 39.01M |
| 316 | PRQR | ProQR Therapeutics N.V. | 155.23M | -4.35% | 881,572 | 23.46M |
| 317 | VRXA | Veraxa Biotech AG | 145.65M | -0.96% | 104,297 | 29.54K |
| 318 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 144.85M | -6.96% | 576,715 | - |
| 319 | TARA | Protara Therapeutics, Inc. | 144.07M | 0.86% | 1,149,623 | - |
| 320 | RNA | Atrium Therapeutics, Inc. | 143.23M | 2.47% | 220,812 | 38.82M |
| 321 | STRO | Sutro Biopharma, Inc. | 141.11M | -4.71% | 307,207 | 45.11M |
| 322 | IVVD | Invivyd, Inc. | 139.09M | -8.21% | 6,747,796 | 60.69M |
| 323 | HUMA | Humacyte, Inc. | 138.90M | -0.20% | 3,935,390 | 2.40M |
| 324 | PYPD | PolyPid Ltd. | 138.58M | 0.31% | 313,545 | - |
| 325 | MENS | Jyong Biotech Ltd. | 138.07M | 3.33% | 69,522 | - |
| 326 | SION | Sionna Therapeutics, Inc. | 134.35M | -3.26% | 515,094 | - |
| 327 | ZNTL | Zentalis Pharmaceuticals, Inc. | 133.64M | -8.72% | 1,210,586 | 26.87M |
| 328 | YARW | Yarrow Bioscience, Inc. | 133.52M | 0.99% | 172,839 | - |
| 329 | FATE | Fate Therapeutics, Inc. | 127.65M | 2.94% | 1,872,072 | 4.75M |
| 330 | MSLE | Satellos Bioscience Inc. | 127.61M | -4.19% | 92,326 | - |
| 331 | CDXS | Codexis, Inc. | 126.04M | 7.48% | 1,466,693 | 88.34M |
| 332 | MGNX | MacroGenics, Inc. | 125.90M | -3.90% | 720,173 | 140.81M |
| 333 | ALXO | ALX Oncology Holdings Inc. | 125.41M | -3.47% | 563,736 | - |
| 334 | ENGN | enGene Therapeutics Inc. | 123.98M | 7.56% | 2,805,866 | - |
| 335 | ADAG | Adagene Inc. | 122.20M | 22.97% | 1,296,525 | 9.29M |
| 336 | NRXP | NRx Pharmaceuticals, Inc. | 121.14M | 14.29% | 2,161,520 | 4.31M |
| 337 | ARMP | Armata Pharmaceuticals, Inc. | 117.90M | 19.17% | 89,183 | 7.56M |
| 338 | SPRB | Spruce Biosciences, Inc. | 117.37M | 0.86% | 63,334 | 697.00K |
| 339 | RTSN | Retension Pharmaceuticals, Inc. | 115.73M | 21.74% | 108,911 | - |
| 340 | NTHI | NeOnc Technologies Holdings, Inc. | 115.53M | -3.93% | 279,640 | 39.99K |
| 341 | OKUR | OnKure Therapeutics, Inc. | 114.22M | 9.30% | 172,684 | - |
| 342 | UPB | Upstream Bio, Inc. | 114.01M | -0.95% | 1,239,160 | 2.87M |
| 343 | CMPX | Compass Therapeutics, Inc. | 110.03M | 0.71% | 1,788,314 | 850.00K |
| 344 | CNTN | Canton Strategic Holdings, Inc. | 108.99M | -5.99% | 640,222 | 4.47M |
| 345 | NERV | Minerva Neurosciences, Inc. | 108.64M | 0.93% | 278,417 | - |
| 346 | FHTX | Foghorn Therapeutics Inc. | 107.33M | -2.19% | 529,080 | 112.13M |
| 347 | NBP | NovaBridge Biosciences | 104.76M | 9.83% | 873,871 | - |
| 348 | CBUS | Cibus, Inc. | 104.71M | -1.44% | 255,474 | 4.53M |
| 349 | UNCY | Unicycive Therapeutics, Inc. | 104.19M | -3.51% | 1,389,327 | - |
| 350 | VYGR | Voyager Therapeutics, Inc. | 103.92M | 9.87% | 840,372 | 25.11M |
| 351 | TLSA | Tiziana Life Sciences Ltd | 103.50M | 24.75% | 1,282,105 | - |
| 352 | IMUX | Immunic, Inc. | 102.61M | 2.59% | 175,372 | - |
| 353 | ICCC | ImmuCell Corporation | 102.17M | -0.71% | 10,679 | 33.21M |
| 354 | MOLN | Molecular Partners AG | 101.84M | -6.82% | 484 | 856.30K |
| 355 | IPHA | Innate Pharma S.A. | 101.51M | -22.56% | 503,029 | 11.21M |
| 356 | LENZ | LENZ Therapeutics, Inc. | 100.86M | -8.29% | 622,157 | 12.36M |
| 357 | GNLX | Genelux Corporation | 100.38M | 12.00% | 801,033 | 8.00K |
| 358 | OTLK | Outlook Therapeutics, Inc. | 99.30M | 13.12% | 4,662,577 | -1.16M |
| 359 | VANI | Vivani Medical, Inc. | 94.71M | 0.00% | 177,883 | - |
| 360 | ANIX | Anixa Biosciences, Inc. | 94.21M | 1.50% | 287,691 | - |
| 361 | ZURA | Zura Bio Limited | 92.96M | -6.75% | 3,028,444 | - |
| 362 | PMVP | PMV Pharmaceuticals, Inc. | 92.15M | 0.00% | 430,826 | - |
| 363 | RANI | Rani Therapeutics Holdings, Inc. | 90.38M | 15.86% | 1,199,939 | 6.58M |
| 364 | HURA | TuHURA Biosciences, Inc. | 87.31M | -2.14% | 194,093 | - |
| 365 | EQ | Equillium, Inc. | 86.20M | -9.09% | 889,843 | 4.39M |
| 366 | NKTX | Nkarta, Inc. | 82.46M | -8.00% | 811,253 | - |
| 367 | BDTX | Black Diamond Therapeutics, Inc. | 82.18M | -0.69% | 603,007 | 70.00M |
| 368 | RLYB | Rallybio Corporation | 82.16M | -0.20% | 28,935 | 434.00K |
| 369 | SEER | Seer, Inc. | 80.37M | -1.37% | 231,511 | 14.08M |
| 370 | MAIA | MAIA Biotechnology, Inc. | 80.28M | 4.00% | 2,267,601 | - |
| 371 | PLYX | Polaryx Therapeutics, Inc. | 80.25M | 0.63% | 22,134 | - |
| 372 | CLLS | Cellectis S.A. | 78.83M | -2.83% | 6,016 | 32.10M |
| 373 | TENX | Tenax Therapeutics, Inc. | 76.66M | 0.70% | 1,505,978 | - |
| 374 | KZIA | Kazia Therapeutics Limited | 75.23M | 3.39% | 229,813 | 1.32M |
| 375 | CING | Cingulate Inc. | 74.31M | 8.26% | 951,217 | - |
| 376 | CNXU | Conexeu Sciences Inc. | 72.61M | 17.75% | 434,073 | - |
| 377 | COYA | Coya Therapeutics, Inc. | 72.48M | 2.32% | 150,400 | 4.69M |
| 378 | TNYA | Tenaya Therapeutics, Inc. | 69.95M | -4.93% | 2,770,291 | 3.03M |
| 379 | GOSS | Gossamer Bio, Inc. | 69.91M | 3.53% | 242,583 | 78.42M |
| 380 | NMRA | Neumora Therapeutics, Inc. | 69.21M | 9.66% | 1,495,205 | - |
| 381 | NRXS | NeurAxis, Inc. | 69.12M | 5.64% | 225,415 | 6.53M |
| 382 | ATRA | Atara Biotherapeutics, Inc. | 68.98M | 4.15% | 15,307 | 3.97M |
| 383 | ACRV | Acrivon Therapeutics, Inc. | 66.85M | 9.09% | 612,606 | - |
| 384 | AVXL | Anavex Life Sciences Corp. | 66.69M | -2.78% | 1,070,989 | - |
| 385 | MNOV | MediciNova, Inc. | 65.46M | -0.75% | 115,565 | 935.72K |
| 386 | CRDF | Cardiff Oncology, Inc. | 65.27M | -0.87% | 864,756 | 559.00K |
| 387 | MIST | Milestone Pharmaceuticals Inc. | 64.88M | 11.42% | 2,229,477 | 5.31M |
| 388 | CHRS | Coherus Oncology, Inc. | 63.35M | -14.34% | 2,557,489 | 53.64M |
| 389 | FBIO | Fortress Biotech, Inc. | 63.03M | 3.85% | 414,542 | 69.99M |
| 390 | CSBR | Champions Oncology, Inc. | 61.80M | -3.31% | 11,725 | 60.66M |
| 391 | IBIO | iBio, Inc. | 59.75M | 13.37% | 850,846 | 1.08M |
| 392 | NTRB | Nutriband Inc. | 58.59M | -13.77% | 28,041 | 1.62M |
| 393 | OKYO | OKYO Pharma Limited | 57.73M | -0.45% | 235,407 | - |
| 394 | CGTX | Cognition Therapeutics, Inc. | 57.06M | -4.75% | 340,289 | - |
| 395 | PDSB | PDS Biotechnology Corporation | 56.83M | -12.27% | 4,295,628 | - |
| 396 | BOLD | Boundless Bio, Inc. | 56.66M | -0.41% | 153,051 | - |
| 397 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 56.57M | -8.80% | 635,314 | - |
| 398 | ONCY | Oncolytics Biotech Inc. | 56.14M | 15.11% | 2,185,248 | - |
| 399 | NORD | Nordicus Partners Corporation | 55.59M | 3.26% | 22,775 | - |
| 400 | TNXP | Tonix Pharmaceuticals Holding Corp. | 54.80M | -4.08% | 1,046,339 | 43.05M |
| 401 | AZR | Azora Therapeutics, Inc. | 54.29M | 3.68% | 217,366 | - |
| 402 | RNXT | RenovoRx, Inc. | 54.04M | 7.69% | 841,313 | 2.78M |
| 403 | XLO | Xilio Therapeutics, Inc. | 53.90M | 1.19% | 8,083 | 55.01M |
| 404 | IBO | Impact BioMedical Inc. | 53.31M | 0.00% | - | 38.00K |
| 405 | XBIT | XBiotech Inc. | 52.74M | -2.81% | 60,735 | - |
| 406 | ANVS | Annovis Bio, Inc. | 52.16M | 13.16% | 1,313,314 | - |
| 407 | HRTX | Heron Therapeutics, Inc. | 51.94M | -3.26% | 1,827,515 | 148.22M |
| 408 | SPRO | Spero Therapeutics, Inc. | 50.90M | -3.03% | 272,966 | 41.56M |
| 409 | HOWL | Werewolf Therapeutics, Inc. | 50.06M | -1.90% | 1,850,429 | 21.00M |
| 410 | GANX | Gain Therapeutics, Inc. | 49.42M | -5.93% | 1,155,922 | - |
| 411 | CLNN | Clene Inc. | 49.25M | 6.21% | 239,633 | 238.00K |
| 412 | VRCA | Verrica Pharmaceuticals Inc. | 49.05M | -9.08% | 43,853 | 22.89M |
| 413 | MREO | Mereo BioPharma Group plc | 46.20M | 5.39% | 864,435 | 800.00K |
| 414 | INKT | MiNK Therapeutics, Inc. | 45.11M | -4.84% | 44,953 | 200.00K |
| 415 | ELTX | Elicio Therapeutics, Inc. | 45.01M | 11.19% | 550,610 | - |
| 416 | IMA | ImageneBio, Inc. | 43.25M | -2.31% | 6,196 | 800.00K |
| 417 | CNTB | Connect Biopharma Holdings Limited | 42.90M | 14.93% | 680,819 | 3.67M |
| 418 | OSTX | OS Therapies Incorporated | 42.50M | 23.51% | 1,305,461 | - |
| 419 | HYFT | MindWalk Holdings Corp. | 42.40M | -0.74% | 353,093 | 11.57M |
| 420 | ELOX | Eloxx Pharmaceuticals, Inc. | 42.02M | -11.33% | 25,201 | - |
| 421 | DWTX | Dogwood Therapeutics, Inc. | 41.29M | 0.00% | 183,965 | 100.00K |
| 422 | PLRX | Pliant Therapeutics, Inc. | 40.93M | 0.12% | 945,200 | - |
| 423 | ALDX | Aldeyra Therapeutics, Inc. | 40.51M | -3.29% | 527,634 | - |
| 424 | ALPS | Alps Group Inc | 39.60M | 1.71% | 20,597 | 3.74M |
| 425 | VERU | Veru Inc. | 39.39M | 7.94% | 467,351 | 16.89M |
| 426 | BMEA | Biomea Fusion, Inc. | 38.52M | 8.61% | 1,043,047 | - |
| 427 | HYPD | Hyperion DeFi, Inc. | 36.91M | -0.21% | 244,506 | 1.91M |
| 428 | TIL | Instil Bio, Inc. | 36.83M | 0.56% | 119,802 | - |
| 429 | APLM | Apollomics, Inc. | 36.44M | -2.32% | 9,906 | 445.00K |
| 430 | GRCE | Grace Therapeutics, Inc. | 36.39M | 0.58% | 27,680 | - |
| 431 | CRBU | Caribou Biosciences, Inc. | 35.23M | -4.29% | 3,374,572 | 9.44M |
| 432 | CUE | Cue Biopharma, Inc. | 34.58M | 68.20% | 13,229,241 | 35.64M |
| 433 | SER | Serina Therapeutics, Inc. | 34.29M | -1.10% | - | 125.00K |
| 434 | ATNM | Actinium Pharmaceuticals, Inc. | 33.96M | -20.00% | 326,840 | 35.00M |
| 435 | ATHE | Alterity Therapeutics Limited | 33.06M | -8.85% | 25,692 | 2.50M |
| 436 | KLRS | Kalaris Therapeutics, Inc. | 32.61M | -4.20% | 53,146 | - |
| 437 | INMB | INmune Bio Inc. | 31.89M | 7.29% | 770,692 | 50.00K |
| 438 | EXOZ | eXoZymes, Inc. | 31.84M | 3.63% | 19,403 | -700.00 |
| 439 | NXTC | NextCure, Inc. | 31.53M | 2.76% | 21,403 | - |
| 440 | TELO | Telomir Pharmaceuticals, Inc. | 30.98M | -0.61% | 151,191 | - |
| 441 | EYPT | EyePoint, Inc. | 30.95M | -8.08% | 3,610,328 | 2.58M |
| 442 | RNTX | Rein Therapeutics Inc. | 30.65M | -0.31% | 815,803 | - |
| 443 | NNVC | NanoViricides, Inc. | 30.37M | 2.59% | 182,388 | - |
| 444 | BCTX | BriaCell Therapeutics Corp. | 28.36M | -6.55% | 59,296 | - |
| 445 | PMN | ProMIS Neurosciences, Inc. | 28.07M | -2.49% | 88,018 | - |
| 446 | EDSA | Edesa Biotech, Inc. | 27.83M | 5.10% | 281,012 | - |
| 447 | FLNA | Filana Therapeutics, Inc. | 27.40M | 13.33% | 848,525 | - |
| 448 | PTHS | Pelthos Therapeutics Inc. | 27.18M | 3.80% | 84,199 | 51.29M |
| 449 | ACET | Adicet Bio, Inc. | 26.91M | -10.07% | 832,756 | - |
| 450 | PLRZ | Polyrizon Ltd. | 26.79M | 3.57% | 12,339 | - |
| 451 | LONA | LeonaBio, Inc. | 24.97M | -3.99% | 44,498 | - |
| 452 | CVM | CEL-SCI Corporation | 24.27M | -25.41% | 615,783 | - |
| 453 | LITS | Lite Strategy, Inc. | 24.12M | 1.56% | 148,649 | - |
| 454 | ABVC | ABVC BioPharma, Inc. | 23.89M | -3.15% | 102,158 | 797.92K |
| 455 | MGX | Metagenomi Therapeutics, Inc. | 23.89M | 0.13% | 86,527 | 7.09M |
| 456 | GRDX | GridAI Technologies Corp. | 23.79M | 1.82% | 152,113 | - |
| 457 | EVAX | Evaxion A/S | 23.43M | -8.63% | 94,608 | 7.49M |
| 458 | RNAZ | TransCode Therapeutics, Inc. | 23.27M | -4.61% | 18,063 | - |
| 459 | IMMP | Immutep Limited | 22.75M | -0.31% | 138,152 | 13.79M |
| 460 | IGC | IGC Pharma, Inc. | 22.71M | 3.57% | 684,076 | 1.11M |
| 461 | CRVO | CervoMed Inc. | 21.94M | -3.33% | 295,166 | 8.73K |
| 462 | AARD | Aardvark Therapeutics, Inc. | 19.92M | -20.87% | 530,041 | - |
| 463 | COCP | Cocrystal Pharma, Inc. | 18.82M | -3.28% | 8,020 | 435.00K |
| 464 | BYSI | BeyondSpring Inc. | 18.63M | -19.09% | 52,691 | 1.88M |
| 465 | ATOS | Atossa Therapeutics, Inc. | 18.06M | -4.74% | 43,783 | - |
| 466 | QNRX | Quoin Pharmaceuticals, Ltd. | 17.10M | 5.95% | 7,037 | - |
| 467 | KTTA | Pasithea Therapeutics Corp. | 17.07M | 17.64% | 797,128 | - |
| 468 | LPCN | Lipocine Inc. | 16.83M | -5.00% | 63,090 | 3.74M |
| 469 | CELU | Celularity Inc. | 15.68M | -15.41% | 653,734 | 18.67M |
| 470 | NCEL | NewcelX Ltd. | 15.31M | -1.12% | 4,314 | - |
| 471 | CNTX | Context Therapeutics Inc. | 15.29M | -2.69% | 1,244,150 | - |
| 472 | BSEM | BioStem Technologies, Inc. | 15.21M | -12.49% | 187,107 | 31.75M |
| 473 | AKTX | Akari Therapeutics, Plc | 15.20M | 16.67% | 9,921 | - |
| 474 | MCRB | Seres Therapeutics, Inc. | 14.68M | 2.13% | 42,968 | 2.13M |
| 475 | ESLA | Estrella Immunopharma, Inc. | 14.48M | 0.39% | 446,875 | - |
| 476 | GUTS | Fractyl Health, Inc. | 14.33M | 11.87% | 381,125 | 3.00K |
| 477 | MRKR | Marker Therapeutics, Inc. | 14.23M | 1.98% | 105,817 | 2.31M |
| 478 | ABOS | Acumen Pharmaceuticals, Inc. | 14.06M | -15.51% | 3,053,114 | - |
| 479 | CTXR | Citius Pharmaceuticals, Inc. | 14.02M | -1.56% | 68,049 | 7.11M |
| 480 | ALLR | Allarity Therapeutics, Inc. | 13.87M | 3.69% | 290,794 | 350.00K |
| 481 | TVRD | Tvardi Therapeutics, Inc. | 13.87M | 2.97% | 69,549 | - |
| 482 | ACTU | Actuate Therapeutics, Inc. | 13.51M | -2.38% | 22,074,773 | - |
| 483 | QNTM | Quantum BioPharma Ltd. | 13.32M | -4.40% | 138,232 | - |
| 484 | PASG | Passage Bio, Inc. | 13.31M | -2.01% | 14,482 | - |
| 485 | PLUR | Pluri Inc. | 13.16M | -6.62% | 35,077 | 1.46M |
| 486 | JSPR | Jasper Therapeutics, Inc. | 12.78M | 11.41% | 19,298 | - |
| 487 | NEUP | Neuphoria Therapeutics Inc. | 12.34M | 0.44% | 24,224 | 1.17M |
| 488 | BCDA | BioCardia, Inc. | 11.69M | -2.06% | 22,922 | 3.00K |
| 489 | DYAI | Dyadic International, Inc. | 11.66M | 1.30% | 124,905 | 3.09M |
| 490 | CMMB | Chemomab Therapeutics Ltd. | 11.23M | -5.49% | 37,688 | - |
| 491 | HIND | Vyome Holdings, Inc. | 10.60M | -2.27% | 7,775 | 153.10K |
| 492 | PPBT | Purple Biotech Ltd | 10.49M | 0.00% | 21,978 | - |
| 493 | ATYR | aTyr Pharma, Inc. | 10.40M | -18.24% | 117,845 | 190.00K |
| 494 | BIVI | BioVie Inc. | 10.11M | -5.27% | 186,624 | - |
| 495 | TCRX | TScan Therapeutics, Inc. | 10.06M | -1.72% | 656,745 | 5.19M |
| 496 | BOLT | Bolt Biotherapeutics, Inc. | 10.03M | -9.73% | 103,006 | 4.70M |
| 497 | GDTC | CytoMed Therapeutics Limited | 9.91M | 6.00% | 5,130 | 609.73K |
| 498 | PBM | Psyence Biomedical Ltd. | 9.57M | 0.00% | 63,326 | - |
| 499 | PTN | Palatin Technologies, Inc. | 9.41M | -3.92% | 11,180 | 4.70M |
| 500 | BLRX | BioLineRx Ltd. | 9.34M | 2.68% | 295,216 | 1.39M |